
Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency.  Several studies presented at the annual AABB meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtained through apheresis.

